美国对肝细胞癌肝移植中种族差异的认识不断提高。
Increasing Awareness on Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States.
作者信息
Frenette Catherine T
机构信息
Department of Organ Transplantation, Scripps Center for Organ Transplant Scripps Green Hospital La Jolla CA.
出版信息
Hepatol Commun. 2019 Jan 1;3(1):5-7. doi: 10.1002/hep4.1299. eCollection 2019 Jan.
Abstract
Hepatocellular carcinoma (HCC) is one of the main indications for liver transplantation in the United States. Studies have shown racial disparities in rates of liver transplant for HCC. The underlying etiologies of these disparities are important to understand in order to overcome barriers to liver transplant in disadvantaged racial and ethnic groups.
摘要
肝细胞癌（HCC）是美国肝移植的主要适应症之一。研究表明，HCC肝移植率存在种族差异。了解这些差异的潜在病因对于克服弱势种族和族裔群体肝移植的障碍至关重要。
相似文献
1
Increasing Awareness on Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States.美国对肝细胞癌肝移植中种族差异的认识不断提高。
Hepatol Commun. 2019 Jan 1;3(1):5-7. doi: 10.1002/hep4.1299. eCollection 2019 Jan.
2
Burden of hepatocellular carcinoma among hispanics in South Texas: a systematic review.南德克萨斯州西班牙裔人群肝细胞癌负担：一项系统评价
Biomark Res. 2017 Apr 21;5:15. doi: 10.1186/s40364-017-0096-5. eCollection 2017.
3
Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma: Analysis of the National Inpatient Sample From 2007 to 2014.种族差异在肝细胞癌肝移植中的表现：2007 年至 2014 年全国住院患者样本分析。
J Clin Gastroenterol. 2023 Mar 1;57(3):311-316. doi: 10.1097/MCG.0000000000001675.
4
Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma.肝细胞癌的风险因素以及种族和民族差异评估。
JGH Open. 2020 Apr 15;4(3):351-359. doi: 10.1002/jgh3.12336. eCollection 2020 Jun.
5
Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002.1998 - 2002年美国肝细胞癌肝移植利用方面的种族差异
Am J Gastroenterol. 2008 Jan;103(1):120-7. doi: 10.1111/j.1572-0241.2007.01634.x. Epub 2007 Nov 15.
6
Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.早期肝细胞癌患者在获得医疗服务和生存方面的种族/族裔差异。
Arch Surg. 2010 Dec;145(12):1158-63. doi: 10.1001/archsurg.2010.272.
7
NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.NASH 成为女性肝移植首要原因：肝移植适应证的最新分析及种族和性别差异
Am J Gastroenterol. 2018 Nov;113(11):1649-1659. doi: 10.1038/s41395-018-0088-6. Epub 2018 Jun 8.
8
Characterization of Hepatitis B and C Among Liver Transplant Recipients With Hepatocellular Carcinoma: An Analysis of the Nationwide Inpatient Sample Database.肝细胞癌肝移植受者中乙型和丙型肝炎的特征：基于全国住院患者样本数据库的分析
Transplant Proc. 2016 Jan-Feb;48(1):123-7. doi: 10.1016/j.transproceed.2015.12.008.
9
Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.种族、民族和社会经济地位影响美国肝细胞癌患者的生存率。
Cancer. 2010 Mar 1;116(5):1367-77. doi: 10.1002/cncr.24817.
10
Racial disparities in clinical presentation, surgical procedures, and hospital outcomes among patients with hepatocellular carcinoma in the United States.美国肝细胞癌患者在临床表现、手术程序和医院治疗结果方面的种族差异。
Cancer Epidemiol. 2023 Feb;82:102317. doi: 10.1016/j.canep.2022.102317. Epub 2022 Dec 23.
引用本文的文献
1
Racial Disparities in Liver Transplant for Hepatitis C-Associated Hepatocellular Carcinoma.丙型肝炎相关肝细胞癌肝移植中的种族差异
Ann Surg Oncol. 2025 Jan;32(1):426-437. doi: 10.1245/s10434-024-16317-2. Epub 2024 Oct 16.
2
Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States: An Update.美国肝细胞癌肝移植中的种族差异：最新进展。
Dig Dis Sci. 2023 Oct;68(10):4050-4059. doi: 10.1007/s10620-023-08084-z. Epub 2023 Aug 16.
3
Targeted Molecular Therapeutic Options for Hepatocellular Carcinoma.肝细胞癌的靶向分子治疗选择。
Crit Rev Oncog. 2020;25(1):47-55. doi: 10.1615/CritRevOncog.2020034985.
本文引用的文献
1
Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma Are Not Explained by Differences in Comorbidities, Liver Disease Severity, or Tumor Burden.肝细胞癌肝移植中的种族差异无法用合并症、肝病严重程度或肿瘤负荷的差异来解释。
Hepatol Commun. 2018 Dec 3;3(1):52-62. doi: 10.1002/hep4.1277. eCollection 2019 Jan.
2
Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.肝细胞癌诊断分期中种族/族裔特异性差异及其对根治性治疗接受情况的影响
J Clin Gastroenterol. 2016 May-Jun;50(5):423-30. doi: 10.1097/MCG.0000000000000448.
3
Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?美国肝细胞癌的流行病学：我们目前的状况如何？我们将何去何从？
Hepatology. 2014 Nov;60(5):1767-75. doi: 10.1002/hep.27222. Epub 2014 Aug 25.
4
Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry.近期肝细胞癌患者的种族差异与肝移植率：监测、流行病学和最终结果登记处的结果
Liver Transpl. 2014 May;20(5):528-35. doi: 10.1002/lt.23820. Epub 2014 Feb 25.
5
Estimating the economic burden of racial health inequalities in the United States.估算美国种族健康不平等造成的经济负担。
Int J Health Serv. 2011;41(2):231-8. doi: 10.2190/HS.41.2.c.
Zotero 插件